Evidence map›Paper›PMID 41454504›Full record

ArticlePolish journal of microbiology2025

In vitro Antibiotic Susceptibility of Bacterial Isolates from Polish patients with Cystic Fibrosis: A Non-Interventional Study.

Justyna Milczewska, Wojciech Skorupa, Katarzyna Walicka-Serzysko, Daria Springer, Ewa Kołda, Szczepan Cofta, Violetta Petroniec, Joanna Nowak, Anna Schneider, Anna Mól and 2 more

Abstract read
In one paragraph

Article in Polish journal of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Justyna MilczewskaCystic Fibrosis Department, Institute of Mother and Child, Warsaw, Poland.
Wojciech SkorupaDepartment of Lung Diseases, Institute for Tuberculosis and Lung Diseases, Warsaw, Poland.
Katarzyna Walicka-SerzyskoCystic Fibrosis Department, Institute of Mother and Child, Warsaw, Poland.
Daria SpringerHeliodor Święcicki Clinical Hospital of the Karol Marcinkowski Medical University in Poznań, Poznań, Poland.
Ewa KołdaPulmonology Department, Greater Poland Center for Pulmonology and Thoracic Surgery in Poznań, Poznań, Poland.
Szczepan CoftaHeliodor Święcicki Clinical Hospital of the Karol Marcinkowski Medical University in Poznań, Poznań, Poland.
Violetta PetroniecDepartment of Microbiology, Institute for Tuberculosis and Lung Diseases, Warsaw, Poland.
Joanna NowakDepartment of Microbiology, Institute for Tuberculosis and Lung Diseases, Warsaw, Poland.
Anna SchneiderMicrobiology Laboratory, University Clinical Hospital in Poznań, Poznań, Poland.
Anna MólHeliodor Święcicki Clinical Hospital of the Karol Marcinkowski Medical University in Poznań, Poznań, Poland.
Monika BogielPfizer Polska Sp. z o.o., Warsaw, Poland.
Dorota SandsCystic Fibrosis Department, Institute of Mother and Child, Warsaw, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This non-interventional study was conducted at three cystic fibrosis (CF) treatment centers in Poland from August 2022 to July 2023. The aim was to assess the etiology of bacterial infection and evaluate antimicrobial susceptibility in CF patients. Prevalent pathogens were identified and their

Indexed as

Anti-Bacterial AgentsBacteriaBacterial InfectionsCystic FibrosisAdolescentAdultChildChild, PreschoolDrug Resistance, BacterialDrug Resistance, Multiple, BacterialFemaleHumansMaleMicrobial Sensitivity TestsPolandPseudomonas aeruginosaAnti-Bacterial Agentsantimicrobial susceptibilitybacterial infectionscystic fibrosismultidrug resistancerespiratory pathogens

Identifiers

PMID41454504
PMCPMC12743183

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.